Protalix BioTherapeutics Inc (PLX)
1.15
-0.03
(-2.54%)
USD |
NYAM |
Apr 26, 16:00
1.15
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Gross Profit (Quarterly): 1.63M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.63M |
September 30, 2023 | 5.452M |
June 30, 2023 | 28.93M |
March 31, 2023 | 6.503M |
December 31, 2022 | 6.22M |
September 30, 2022 | 7.109M |
June 30, 2022 | 4.666M |
March 31, 2022 | 10.05M |
December 31, 2021 | 5.401M |
September 30, 2021 | 8.351M |
June 30, 2021 | 1.694M |
March 31, 2021 | 6.555M |
December 31, 2020 | 16.74M |
September 30, 2020 | 7.922M |
June 30, 2020 | 9.14M |
March 31, 2020 | 18.22M |
December 31, 2019 | 14.81M |
September 30, 2019 | 11.04M |
June 30, 2019 | 9.552M |
March 31, 2019 | 8.394M |
December 31, 2018 | 8.075M |
September 30, 2018 | 10.42M |
June 30, 2018 | 2.655M |
March 31, 2018 | 3.79M |
December 31, 2017 | 2.751M |
Date | Value |
---|---|
September 30, 2017 | 1.46M |
June 30, 2017 | 0.835M |
March 31, 2017 | 0.801M |
December 31, 2016 | 0.129M |
September 30, 2016 | 0.422M |
June 30, 2016 | 0.094M |
March 31, 2016 | 0.156M |
December 31, 2015 | 0.00 |
September 30, 2015 | 1.113M |
June 30, 2015 | 1.111M |
March 31, 2015 | 1.41M |
December 31, 2014 | -3.407M |
September 30, 2014 | 1.909M |
June 30, 2014 | 1.081M |
March 31, 2014 | 3.31M |
December 31, 2013 | -6.515M |
September 30, 2013 | 1.772M |
June 30, 2013 | 1.746M |
March 31, 2013 | 2.997M |
December 31, 2012 | -1.13M |
September 30, 2012 | 3.023M |
June 30, 2012 | 21.98M |
March 31, 2012 | 2.408M |
December 31, 2011 | 0.294M |
September 30, 2011 | 0.677M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.63M
Minimum
Dec 2023
28.93M
Maximum
Jun 2023
9.473M
Average
7.922M
Median
Sep 2020
Gross Profit (Quarterly) Benchmarks
Agenus Inc | 16.82M |
InfuSystems Holdings Inc | 14.88M |
AIM ImmunoTech Inc | 0.053M |
Perspective Therapeutics Inc | -- |
Armata Pharmaceuticals Inc | -- |